Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Compass Pathways (NASDAQ:CMPS) executives outlined plans for a potential U.S. regulatory filing and commercial launch ...
Bigger is better, right? Well, maybe not always. Here are 10 cars powered by small-capacity, in-line six-cylinder engines.
All animal studies were performed according to protocols approved by the University Committee on Animal Resources at the University of Rochester Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results